Previous Article | Next Article ![]()
Infection and Immunity, May 1999, p. 2172-2177, Vol. 67, No. 5
AgResearch, Wallaceville Animal Research
Centre, Upper Hutt, New Zealand
Received 12 November 1998/Returned for modification 4 January
1999/Accepted 5 February 1999
Comparison of immune responses induced in cattle by virulent and
attenuated strains of Mycobacterium bovis will assist in identifying responses associated with resistance or susceptibility to
disease. Four strains of M. bovis, one which is virulent in guinea pigs (WAg201) and three which are attenuated in guinea pigs (an
isoniazid-resistant strain [WAg405], ATCC 35721, and BCG) were
compared for their abilities to induce immune responses in cattle and
to grow in bovine lung alveolar macrophage cultures. Extensive
macroscopic lesions were found only in cattle inoculated with the
virulent M. bovis strain. Strong antibody responses to M. bovis culture filtrate, as well as persistently high
levels of gamma interferon and interleukin-2 released from purified
protein derivative (PPD)-stimulated peripheral blood lymphocyte
cultures, were observed in the cattle inoculated with the virulent
strain compared to those inoculated with the attenuated strains. All cattle inoculated with the virulent strain or two of the attenuated strains (WAg405 and ATCC 35721) elicited strong delayed-type
hypersensitivity responses to PPD in skin tests, while animals
inoculated with BCG induced only a weak response. The three strains
which produced strong skin test responses proliferated well in bovine
alveolar macrophages and induced high levels of proinflammatory
cytokine mRNAs compared to BCG. Our study showed that skin test
responsiveness to PPD correlated with the ability of the strains to
grow in alveolar macrophages rather than to their pathogenicity in cattle.
Tuberculosis in humans remains a
major health problem worldwide and causes an estimated 3 million deaths
per year. Tuberculosis in cattle is a major economic problem in many
countries, and its transmission to humans is a small but significant
cause of human morbidity and mortality. The main causative organisms
for humans and cattle, respectively, are the closely related species
Mycobacterium tuberculosis and Mycobacterium
bovis. Cattle are similar to humans in exhibiting a wide range of
responses to tuberculosis infection (20). If the initial
infection is not contained by the animal, it may give rise to
progressive pulmonary disease. In tuberculous cattle, a spectrum of
immune responses can develop, but it is not known which responses are
clearly associated with resistance or susceptibility to disease. A
comparison of immune responses induced by virulent and attenuated
strains would contribute to an improved understanding of the
pathogenesis of tuberculosis and could greatly help the rational
development and testing of new vaccines.
Attention has also been directed at identifying the genetic basis of
mycobacterial virulence with the aim of determining how the organism
survives host defenses to cause disease (6, 15). It has been
shown that expression of the katG gene in M. bovis and M. tuberculosis is associated with virulence
and persistence in guinea pigs and mice (16, 25). In the
M. bovis study, a virulent M. bovis strain
(WAg201) was exposed to increasing concentrations of isoniazid (INH).
An INH-resistant strain (WAg405) which had lost catalase activity and
also had a mutation in the inhA gene was produced. In marked
contrast to the parent, this catalase-negative strain was attenuated
for guinea pigs. Integration of a functional katG gene into
this attenuated strain restored full virulence (25). Another
gene that affects the virulence of a member of the M. tuberculosis complex is that for the principal sigma factor, rpoV. Collins et al. (6) found that the virulence
of the attenuated M. bovis ATCC 35721 strain could be
restored by the addition of a wild-type copy of the rpoV
gene. The principal sigma factor is essential to the expression of a
wide range of different genes, and it has not yet been established
which of them in M. bovis ATCC 35721 is affected to cause
the loss of virulence. Similarly, although three major chromosomal
deletions have been recently identified in BCG, the cause of its
attenuation has not yet been established (17).
In this work, the immune responses induced by these three attenuated
strains (WAg405, ATCC 35721, and BCG) in a natural host for M. bovis were compared to those induced by a virulent M. bovis strain (WAg201) by using an experimental model of
tuberculosis in cattle (3, 4). The responses were also
compared to the ability of the M. bovis strains to grow in
bovine alveolar macrophage cultures and to express cytokine mRNAs. The
immune responses induced by the virulent strain could be distinguished
from those induced by the attenuated strains by the strong
antigen-specific serum antibody response and the persistently high
levels of gamma interferon (IFN- Animals.
Twenty female Friesian-cross cattle, approximately
15 months old, were obtained from tuberculosis-free accredited herds
from an area of New Zealand where both farmed and feral animals were free of tuberculosis. Prior to the experiment the cattle tested negative for reactivity to bovine PPD in the whole-blood IFN- Bacterial strains and growth conditions.
The virulent
M. bovis strain, WAg201, is a New Zealand bovine isolate and
was pathogenic in guinea pigs, in which it caused extensive visible
tuberculous lesions in the spleen, liver, and lung (25). The
INH MIC for the INH-resistant daughter strain, WAg405, was 64 µg/ml,
and the strain was shown to be attenuated in guinea pigs, causing no
visible tuberculous lesions (25). M. bovis ATCC
37521 (TMC403), obtained from the American Type Culture Collection, was
also shown to be attenuated in guinea pigs (6). M. bovis BCG Pasteur 1173P2 was used in this study as it had been
used in previous trials in cattle (4, 5). The WAg405 strain
was sensitive to H2O2 at concentrations of 50 µM or greater, whereas the other strains were not sensitive at levels
of up to 200 µM. Strains were cultured in Tween albumin broth
containing Dubos broth base (Difco Laboratories, Detroit, Mich.)
supplemented with 0.006% (vol/vol) alkalinized oleic acid, 0.5%
(wt/vol) albumin fraction V, and 0.25% (wt/vol) glucose. The solid
medium used for M. bovis culture was Middlebrook 7H11 (Difco) supplemented with 0.5% (wt/vol) albumin, 0.2% (wt/vol) glucose, and 1% (wt/vol) sodium pyruvate.
Inoculation of cattle and necropsy procedure.
Groups of
cattle (four per group) were inoculated intratracheally with
106 CFU of the WAg201, WAg405, ATCC 37521, or BCG strain.
The inoculation procedure was carried out as described previously
(4). Briefly, an 80-cm endotracheal tube containing a fine
cannula was inserted per os into the trachea of an anesthetized animal.
A 1.5-ml inoculum containing an M. bovis strain was injected
through the cannula and flushed out with 2 ml of saline. Four
nonchallenged cattle served as controls. Following inoculation of the
M. bovis strains, all of the groups of cattle were kept in
separate fields to minimize any cross-infection between groups. Blood
samples were collected from the animals at 0, 1, 2, 4, 10, and 15 weeks
after the M. bovis inoculation. All cattle were killed by
use of a captive bolt and severance of the carotid artery and
necropsied 15 weeks after inoculation. Procedures for identifying
macroscopic tuberculous lesions, processing for histopathology, and
bacterial culture have been described previously (4).
Samples from pulmonary lymph nodes (left and right bronchial and
anterior and posterior mediastinal) were collected from all of the
animals for bacterial culture. Additional samples were collected from
any tuberculous lesions observed in other lymph nodes or organs.
Antibody ELISA.
The M. bovis culture filtrate was
prepared from M. bovis AN5, the strain used for the
production of bovine PPD for skin testing in New Zealand. The culture
filtrate was diluted to 3 mg/ml in carbonate buffer (pH 9.6) and 100 µl was added to each well of 96-well enzyme-linked immunosorbent
assay (ELISA) plates (Maxisorb; Nunc, Roskilde, Denmark). The plates
were incubated overnight at 4°C, and the antibody ELISA was carried
out as described previously (26). Sera were stored at
IFN-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Immune Responses Induced in Cattle by Virulent and Attenuated
Mycobacterium bovis Strains: Correlation of Delayed-Type
Hypersensitivity with Ability of Strains To Grow in
Macrophages

![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
) and interleukin-2 (IL-2) released
from purified protein derivative (PPD)-stimulated whole-blood cultures.
However, the delayed-type hypersensitivity (DTH) responses to PPD
correlated with the ability of the M. bovis strains to grow
in macrophage cultures and to induce proinflammatory cytokines rather
than to their pathogenicity in cattle.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
assay.
The cattle were grazed in a high-security isolation unit which
contained a series of small separate fields.
20°C until tested. Results were expressed as absorbance indices,
calculated by expressing the value found for the test serum as a
fraction of the binding of a strong positive reference serum
(5) multiplied by 100.
and IL-2 assays.
Heparinized blood was dispersed in
two 1.5-ml aliquots, and 100 µl of either phosphate-buffered saline
(PBS) or bovine PPD (200 µg/ml; supplied by CSL Ltd., Parkville,
Victoria, Australia, in the IFN-
assay kit) was added to the blood
in separate wells. After incubation at 37°C for 24 h, the plasma
supernatants were harvested and their IFN-
levels were measured by
using a sandwich ELISA kit (CSL Ltd.) as described previously
(21). Results were expressed as optical density (OD) indices
(OD for the bovine PPD sample/OD for the PBS sample).
Intradermal test. Animals were inoculated intradermally with a 0.1-ml volume containing 0.1 mg of bovine PPD (Ministry of Agriculture and Forestry, Central Animal Health Laboratory, Upper Hutt, New Zealand; the PPD used for intradermal testing of cattle in New Zealand) in the right side of the neck 15 weeks after the M. bovis inoculation. DTH responses were expressed as the difference between the skin thickness at the time of inoculation and that 72 h later.
Preparation and infection of bovine alveolar macrophages.
Alveolar macrophages were obtained by lavage from freshly excised lungs
of three M. bovis-free cattle and cultured in 96-well microtiter plates in supplemented RPMI containing 10% normal bovine serum as described previously (1). Quadruplicate wells
containing approximately 1 × 105 macrophages per well
were infected with 5 × 105 CFU of each M. bovis strain at a multiplicity of infection (MOI) of 5:1. A
proportion of the macrophages were stimulated sequentially with
recombinant bovine IFN-
(50 U/ml) and lipopolysaccharide (LPS) (0.1 µg/ml; Escherichia coli 026:B6; Sigma Chemical Co., St.
Louis, Mo.) for 20 and 5 h, respectively, prior to infection (2). The recombinant bovine IFN-
used in this study was
produced in the yeast Pichia pastoris. Briefly, the cDNA
encoding the mature bovine IFN-
(amino acids 24 to 166) was isolated
by reverse transcription-PCR (RT-PCR) of RNA prepared from
ConA-stimulated bovine lymphocytes. A construct which placed the mature
IFN-
protein, with a six-histidine tag at the N terminus, in frame
with the yeast MF-
signal sequence was made in the expression vector
pPIC9 (Invitrogen Corp., Carlsbad, Calif.). Recombinant bovine IFN-
was produced by methods described previously (24) and
purified by immobilized metal-chelating affinity chromatography with
Talon (Clontech Laboratories Inc., Palo Alto, Calif.). For the
determination of nitric oxide (NO) production and macrophage-derived
cytokine mRNA expression, alveolar macrophages were cultured in 24-well
plates, and 5 × 105 cells/well were infected with the
M. bovis strains at an MOI of 5:1.
Assessment of mycobacterial growth and production of NO and cytokine mRNAs. Assessment of mycobacterial growth was determined by addition of [3H]uracil to 48-h macrophage cultures and reincubation for 18 h. The cultures were harvested onto glass fiber filters, and radioactivity was counted in a liquid beta-scintillation counter as described previously (2). Cultures which had been formalin fixed on glass coverslips were stained with hematoxylin-eosin and Ziehl-Neelsen solutions and examined by light microscopy for the presence of intracellular bacilli. NO generated by infected macrophages was assayed by measurement of nitrate in 48-h culture supernatants with the Griess reagent (11).
Expression of tumor necrosis factor alpha (TNF-
), IL-1
, and IL-6
mRNAs in macrophages was determined by RT-PCR at 24 h after infection. RNA was extracted from macrophages and reverse transcribed into cDNA as previously described (2). PCR primers for the cytokines and the constitutively expressed
-actin gene were as described previously (1). The levels of TNF-
mRNA were
quantified by competitive PCR with a competitive template. This was
constructed by introducing an 83-bp deletion into the cDNA amplified by
the TNF-
-specific primers. Serial dilutions of the competitive
template were added to PCR mixtures containing 40 ng of each cDNA to be quantified. Following amplification for 27 cycles, the reaction products were separated by agarose gel electrophoresis and visualized by staining with ethidium bromide.
Statistical analysis.
Analyses of antibody, IFN-
and IL-2
responses, incorporation of [3H]uracil, and TNF-
mRNA
expression were undertaken by using analysis of variance on
loge-transformed data, while the analysis of
skin test responses was by analysis of variance on raw data.
| |
RESULTS |
|---|
|
|
|---|
Pathological and bacteriological findings.
The cattle were
killed and examined at post mortem 15 weeks after inoculation.
Tuberculous lesions, consisting of multiple small foci 3 mm in diameter
or a large consolidated lesion up to 100 mm in diameter, were found in
the lungs of three of the four cattle inoculated with the virulent
WAg201 strain (Table 1). Lesions were
also found in the pulmonary and head lymph nodes of all four animals in
this group and in the mesenteric lymph nodes of one animal. These
lesions ranged in size from 3 to 50 mm in diameter. The ATCC 35721 strain produced small lesions in pulmonary lymph nodes in two of four
animals (ranging from 2 to 3 mm in diameter), but no lesions were
observed in their lungs. M. bovis was recovered from all of
the lesions found in the lungs and pulmonary lymph nodes of the four
animals inoculated with WAg201 and the pulmonary lymph nodes of three
of the four ATCC 35721-inoculated animals. Tuberculous lesions were not
observed in and M. bovis was not cultured from the
WAg405-inoculated, BCG-inoculated, or nonchallenged animals.
|
Development of antibody responses during infection. Cattle inoculated with the virulent WAg201 strain produced a strong antibody response to M. bovis culture filtrate by 10 weeks after inoculation (Fig. 1). In contrast, antibody responses to M. bovis culture filtrate were very low in animals inoculated with either M. bovis WAg405, ATCC 35721, or BCG and in the nonchallenged group. The mean antibody responses observed in the WAg201 group were significantly greater than those in the other groups at 10 and 15 weeks after inoculation (P < 0.05).
|
Development of T-cell responses during infection.
T-cell
responses were measured by the release of IFN-
and IL-2 from
whole-blood cultures stimulated with bovine PPD and by DTH responses to
bovine PPD. Cattle infected with each of the four strains of M. bovis produced strong IFN-
and IL-2 responses which were
significantly greater than those for the nonchallenged group from 2 weeks onwards (P < 0.05) (Fig.
2 and 3).
The mean IFN-
and IL-2 responses for animals inoculated with WAg405,
ATCC 35721, and BCG gradually declined by 4 weeks after inoculation but
remained elevated in cattle infected with the virulent M. bovis WAg201 strain. The mean IFN-
response for the
WAg201-inoculated group at 15 weeks after inoculation was significantly
greater than those for the ATCC 35721-inoculated, BCG-inoculated, and nonchallenged groups (P < 0.05). For the IL-2
responses, the mean response for the WAg201-inoculated group at 10 weeks after inoculation was significantly greater than those for all of
the other groups (P < 0.05).
|
|
|
Growth of M. bovis strains in alveolar macrophages is
related to their ability to induce DTH in cattle and not to the disease
status.
Since the different strains varied in virulence for
cattle, we examined their abilities to grow within bovine alveolar
macrophages, to induce cytokine mRNA expression, and to stimulate NO
production. Metabolic labelling with [3H]uracil was used
as an indirect measure of growth of mycobacteria in macrophages.
Acid-fast staining showed that the bacilli were intracellular following
infection of confluent monolayers, and therefore the uracil counts
reflected intracellular growth of bacteria. The WAg201, WAg405, and
ATCC 35721 strains grew well within the unstimulated macrophages, with
only minor differences in their ability to incorporate uracil (Fig.
5). All of these strains also grew well
in macrophages infected at an MOI of 1:1, although uracil uptake was
proportionally lower than that observed at an MOI of 5:1 (data not
shown). Prior activation of macrophages with IFN-
and LPS resulted
in a significant reduction in growth (P < 0.01). The
growth of M. bovis BCG within both unstimulated and
stimulated macrophages was significantly suppressed compared to that
for the other three strains (P < 0.05). All strains
were capable of growth when cultured in supplemented RPMI containing 10% normal bovine serum, with M. bovis BCG exhibiting a
higher rate of [3H]uracil uptake than the other three
strains (Fig. 5).
|
and LPS markedly increased NO production, but
no differences between macrophages infected with the different strains
were observed (Table 2). Induction of
TNF-
, IL-1
, and IL-6 mRNAs in unstimulated macrophages infected
with the WAg201, WAg405, and ATCC 35721 strains was greater than that
observed in macrophages infected with BCG (Table 2). The levels of
TNF-
mRNA, quantified by competitive PCR, were significantly higher in macrophages infected with WAg201, WAg405, or ATCC 35721 than in
those infected with BCG (P < 0.05). No significant
differences between the levels of TNF-
, IL-1
, and IL-6 mRNAs in
the stimulated macrophages infected with the different strains were
observed, but for the BCG-infected macrophages TNF-
mRNA levels were
higher in the stimulated than in the unstimulated macrophages
(P < 0.05). A comparison of the results from
competitive PCR with the qualitative measurement of cytokine expression
showed that TNF-
transcript levels of 5 × 106
copies/µg of total RNA were equated with a strong signal intensity (designated +++) on an ethidium bromide-stained agarose gel, while levels of 1 × 106 copies/µg of total RNA were
equated with a weak signal (designated +).
|
| |
DISCUSSION |
|---|
|
|
|---|
Three attenuated M. bovis strains with widely varied histories were chosen for this study. BCG has been investigated for many years in a wide range of different animal hosts, and its attenuated nature in these animals is well known; ATCC 35721 was isolated by Karlson in 1950 and found by him to be attenuated in guinea pigs and rabbits; and WAg405 was produced in this laboratory (25). Previously, both WAg405 (25) and ATCC 35721 (6) were shown by us to be attenuated in guinea pigs. In this study all three of these strains were shown to be attenuated in cattle. Apart from ATCC 35721, lesions were not observed in cattle inoculated with these strains, and the lesions that were observed with ATCC 35721 were small and limited in distribution compared with those with the wild-type strain WAg201.
Inoculation of cattle with the virulent strain WAg201 induced an
antigen-specific antibody response, and persistently high levels of
IFN-
and IL-2 were released from antigen-stimulated whole-blood
cultures. In contrast, inoculation of cattle with ATCC 35721, WAg405,
or BCG induced no antibody response but induced IFN-
and IL-2
responses which peaked at 2 to 4 weeks after inoculation and rapidly declined.
In other studies on the experimental infection of cattle with virulent
M. bovis, cell-mediated responses as measured by lymphocyte proliferation and release of IFN-
were seen early in all infected animals, and the appearance of antibody responses correlated with the
severity of disease (12, 18). The persistence of high IFN-
responses in cattle which have developed tuberculous lesions from either experimental (3, 18) or natural (26)
infections and the transient increase in IFN-
responses in cattle
infected with attenuated M. bovis strains support the view
that an active infection is required for induction of strong IFN-
responses in cattle. This situation appears to be different from that
for humans, where M. tuberculosis antigen-induced production
of IFN-
is often depressed in peripheral blood mononuclear cells of
patients with active pulmonary tuberculosis compared to healthy
tuberculin reactors (14, 22, 23). In human tuberculosis the
immunosuppression of cell-mediated immune responses may be associated
with production of transforming growth factor
, as neutralizing
antibody to transforming growth factor
was shown to significantly
increase PPD-stimulated production of IFN-
in tuberculosis patients
but not in contacts (13). In experimental M. bovis infection studies with cattle, increasing the challenge dose
decreased the interval before antibody was detected and increased the
number of lesions and their distribution, while little or no antibody
was detected in tuberculous animals infected naturally (18).
In the present study, there was no correlation between the induction of
DTH responses to bovine PPD and the virulence of the inoculated strain.
Dissociation between IFN-
and DTH responses has been seen in studies
with IFN-
-knockout mice, where the loss of the ability to secrete
IFN-
had a devastating effect on protective immunity against
M. tuberculosis but did not appear to be essential for
induction of a strong DTH response (7). The ability of the
M. bovis strains in the present study to induce a DTH
response correlated with their growth and persistence in bovine
alveolar macrophage cultures. BCG was the only M. bovis
strain which was not able to persist in macrophages, although this
strain grew well in culture medium alone. Activation of the macrophages
by pretreatment with IFN-
and LPS partially controlled the growth of
all of the strains in the macrophage cultures, but the relative differences between the strains in terms of their growth and
persistence in the stimulated cultures were the same as for the
unstimulated cultures.
The induction of proinflammatory cytokine TNF-
, IL-1
, and IL-6
mRNAs from the unstimulated macrophage cultures was associated with the
growth and persistence of M. bovis strains within the macrophages, with a very low induction observed in the BCG-infected macrophages. The levels of proinflammatory cytokine mRNAs in the stimulated macrophage cultures which were infected with M. bovis were similar for all strains, with TNF-
and IL-6
responses being slightly lower than those observed in the unstimulated
cultures infected with either WAg201, WAg405, or ATCC 35721. These
lower responses may have arisen from the partial control of the growth of M. bovis. The increase in cytokine mRNA expression in the
stimulated cultures infected with BCG is more likely to have arisen
from the combined effects of stimulation with IFN-
and LPS.
It has been considered that the pathology resulting from infection with virulent M. tuberculosis strains resulted from the ability of the strains to induce macrophages to synthesize and secrete cytokines (8). There was no indication from our study that production of proinflammatory cytokines from infected macrophages correlates with the virulence of the strain.
There was no association between the growth of the different M. bovis strains within macrophages and the levels of NO generated. However, NO production was markedly enhanced when the macrophages were
stimulated with IFN-
and LPS and was associated with a partial control of growth of all strains. This is in agreement with previous observations that increased induction of NO in stimulated macrophages was associated with a partial restriction of growth of virulent M. bovis, although blocking of NO production with
NG-monomethyl-L-arginine had no
affect on the amount of growth (2). In an earlier study
(1), the kinetics of the growth of BCG and M. bovis in bovine alveolar macrophages was investigated by using
various MOIs with culture for 1 to 4 days. Infection of macrophages by
virulent M. bovis consistently resulted in enhanced bacterial metabolism and induction of proinflammatory cytokines and
reduced the viability of macrophages compared with BCG-infected macrophages (1, 2).
A comparison of the growth rate of the avirulent H37Ra M. tuberculosis strain with that of the virulent H37Rv strain in macrophages showed that H37Ra and H37Rv grew at similar rates in human monocyte-derived macrophages, whereas H37Rv grew more rapidly in murine macrophages (19). However, in a subsequent study using a very low MOI (one live M. tuberculosis organism per 80 cells) and with cultures observed over a 10-day period, H37Rv grew more rapidly than H37Ra in human monocyte-derived macrophages (27).
There is considerable evidence that the ability to overcome the
antibacterial effects of peroxide that is produced in infected macrophages contributes to the virulence of the M. tuberculosis complex (10). In the present study,
although WAg405 was sensitive to H2O2, its
growth rate even when the macrophages were activated with IFN-
and
LPS was comparable to that of its parent catalase-positive strain
WAg201. This indicates that in these short-term macrophage cultures,
the lack of an active catalase/peroxidase is not important for optimum
growth of M. bovis. Nevertheless, WAg405 is avirulent in
both guinea pigs and cattle, so conditions for multiplication and
survival of the organisms in macrophages in vivo appear to be different
from those in vitro.
We have identified that the production of both a strong sustained
cellular immune response, as characterized by high levels of IL-2 and
persistently high levels of IFN-
, and a strong antibody response was
associated with disease. In contrast, the induction of a DTH response
in cattle did not correlate with the pathological status of the animals
but rather was correlated with the ability of the strain to multiply in
bovine alveolar macrophages and to induce a proinflammatory cytokine
response. The marked differences observed between BCG and the other two
attenuated M. bovis strains raise the possibility that
attenuated strains which are more immunogenic than BCG can be
developed, and protection studies using recently attenuated strains are
being planned.
| |
ACKNOWLEDGMENTS |
|---|
We thank Gary Yates, Carol Wilson, Denise Keen, Natalie Parlane, Leong Goh, and Allison McCarthy for excellent assistance, Margot Skinner for validation of the IL-2 bioassay, and Lilian Morrison for the statistical analyses.
This work was financially supported by the New Zealand Ministry of Agriculture and Forestry (Policy Management).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: AgResearch, Wallaceville Animal Research Centre, P.O. Box 40063, Upper Hutt, New Zealand. Phone: 64 45286089. Fax: 64 45281380. E-mail: wedlockn{at}agresearch.cri.nz.
Present address: Department of Microbiology, University of Otago,
Dunedin, New Zealand.
Editor: R. N. Moore
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Aldwell, F. E., D. N. Wedlock, and B. M. Buddle. 1996. Bacterial metabolism, cytokine mRNA transcription and viability of bovine alveolar macrophages infected with Mycobacterium bovis BCG or virulent M. bovis. Immunol. Cell Biol. 74:45-51[Medline]. |
| 2. |
Aldwell, F. E.,
D. N. Wedlock, and B. M. Buddle.
1997.
Sequential activation of alveolar macrophages by IFN- and LPS is required for growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG.
Immunol. Cell Biol.
75:161-166[Medline].
|
| 3. | Buddle, B. M., F. E. Aldwell, A. Pfeffer, G. W. de Lisle, and L. A. Corner. 1994. Experimental Mycobacterium bovis infection of cattle: effect of dose of M. bovis and pregnancy on immune responses and distribution of lesions. N.Z. Vet. J. 42:167-172. |
| 4. | Buddle, B. M., G. W. de Lisle, A. Pfeffer, and F. E. Aldwell. 1995. Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine 13:1123-1130[Medline]. |
| 5. | Buddle, B. M., D. Keen, A. Thomson, G. Jowett, A. R. McCarthy, J. Heslop, G. W. de Lisle, J. L. Stanford, and F. E. Aldwell. 1995. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res. Vet. Sci. 59:10-16[Medline]. |
| 6. |
Collins, D. M.,
R. P. Kawakami,
G. W. de Lisle,
L. Pascopella,
B. R. Bloom, and W. R. Jacobs.
1995.
Mutation of the principal factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex.
Proc. Natl. Acad. Sci. USA
92:8036-8040 |
| 7. |
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
D. G. Griffin,
D. G. Russell, and I. M. Orme.
1993.
Disseminated tuberculosis in IFN- gene-disrupted mice.
J. Exp. Med.
178:2242-2248.
|
| 8. | Dunn, P. L., and R. J. North. 1995. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice. Infect. Immun. 63:3428-3437[Abstract]. |
| 9. | Emery, D. L., J. H. Duffy, and P. R. Wood. 1988. An analysis of cellular proliferation and synthesis of lymphokines and specific antibody in vitro by leucocytes from immunized cattle. Vet. Immunol. Immunopathol. 18:67-80[Medline]. |
| 10. | Gordon, S., and P. W. Andrew. 1996. Mycobacterial virulence factors. J. Appl. Bacteriol. (Symp. Suppl.) 81:10S-22S. |
| 11. | Green, L. C., D. A. Wagner, J. A. Glogowski, P. L. Skipper, J. S. Wishnok, and S. R. Tannenbaum. 1982. Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids. Anal. Biochem. 126:131-138[Medline]. |
| 12. | Hanna, J., S. D. Neill, and J. J. O'Brien. 1992. ELISA tests for antibodies in experimental bovine tuberculosis. Vet. Microbiol. 31:243-249[Medline]. |
| 13. |
Hirsch, C. S.,
R. Hussain,
Z. Toossi,
G. Dawood,
F. Shahid, and J. J. Ellner.
1996.
Cross-modulation by transforming growth factor in human tuberculosis: suppression of antigen-driven blastogenesis and interferon- production.
Proc. Natl. Acad. Sci. USA
93:3193-3198 |
| 14. | Huygen, K., J.-P. Van Vooren, M. Turneer, R. Bosmans, P. Dierckx, and J. De Bruyn. 1988. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial antigen (P32) in patients with active tuberculosis. Scand. J. Immunol. 27:187-194[Medline]. |
| 15. | Jacobs, W. R. 1992. Advances in mycobacterial genetics: new promises for old diseases. Immunobiology 184:147-156[Medline]. |
| 16. | Li, Z., C. Kelly, F. Collins, D. Rouse, and S. Morris. 1998. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J. Infect. Dis. 177:1030-1035[Medline]. |
| 17. |
Mahairas, G. G.,
P. J. Sabo,
M. J. Hickey,
D. C. Singh, and C. K. Stover.
1996.
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis.
J. Bacteriol.
178:1274-1282 |
| 18. | Neill, S. D., J. M. Pollock, G. B. Bryson, and J. Hanna. 1994. Pathogenesis of Mycobacterium bovis infection in cattle. Vet. Microbiol. 40:41-52[Medline]. |
| 19. | Paul, S., P. Laochumroonvorapong, and G. Kaplan. 1996. Comparable growth of virulent and avirulent Mycobacterium tuberculosis in human macrophages in vitro. J. Infect. Dis. 174:105-112[Medline]. |
| 20. | Ritacco, V., B. Lopez, I. N. de Kantor, L. Barrera, F. Errico, and A. Nader. 1991. Reciprocal cellular and humoral responses in bovine tuberculosis. Res. Vet. Sci. 50:365-367[Medline]. |
| 21. | Rothel, J. S., S. L. Jones, L. A. Corner, J. C. Cox, and P. R. Wood. 1990. A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle. Aust. Vet. J. 67:134-137[Medline]. |
| 22. |
Sánchez, F. O.,
J. I. Rodríguez,
G. Agudelo, and L. F. García.
1994.
Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.
Infect. Immun.
62:5673-5678 |
| 23. | Vilcek, J., A. Klion, D. Henriksen-DeStefano, A. Zemtov, D. M. Davidson, M. Davidson, A. E. Friedman-Kien, and J. Le. 1986. Defective gamma-interferon production in peripheral blood leucocytes of patients with acute tuberculosis. J. Clin. Immunol. 6:146-151[Medline]. |
| 24. |
Wedlock, D. N.,
L. P. Goh,
A. R. McCarthy,
R. G. Midwinter,
N. A. Parlane, and B. M. Buddle.
1999.
Physiological effects and adjuvanticity of recombinant brushtail possum TNF- .
Immunol. Cell Biol.
77:28-33[Medline].
|
| 25. | Wilson, T. M., G. W. de Lisle, and D. M. Collins. 1995. Effect of inhA and katG on isoniazid-resistance and virulence of Mycobacterium bovis. Mol. Microbiol. 15:1009-1015[Medline]. |
| 26. | Wood, P. R., L. A. Corner, J. S. Rothel, J. L. Ripper, T. Fifis, B. S. McCormick, B. Francis, L. Melville, K. Small, K. De Witte, J. Tolson, T. J. Ryan, G. W. de Lisle, J. C. Cox, and S. L. Jones. 1992. A field evaluation of serological and cellular diagnostic tests for bovine tuberculosis. Vet. Microbiol. 31:71-79[Medline]. |
| 27. |
Zhang, M.,
J. Gong,
Y. Lin, and P. F. Barnes.
1998.
Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages.
Infect. Immun.
66:794-799 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»